Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit''

Koen Talsma, Bas Wijnhoven, Ewout Steyerberg, Jan van Lanschot

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E42-E43
JournalAnnals of Surgery
Volume265
Issue number4
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this